코미팜
3. April 2020
Therapeutic medicines against the coronavirus infection Covid-19
In a broader sense, one can also count sodium metaarsenite (NaAsO2) among the immune modulators, because it dampens the production of certain messenger substances of the immune system (the cytokines), which can trigger intensive immune reactions. The South Korean company Komipharm has thus developed a medicine against tumour-associated pain (project name PAX-1-001).
It has now applied for clinical trials to test the medicine in Covid-19 patients.
https://www.vfa.de/de/arzneimittel-forschung/woran-wir-forschen/therapeutic-medicines-coronavirus-covid-19#neuemedikamente
전문가방송
연관검색종목 03.28 22:30 기준
0/1000 byte